News Release
- Whats new September 24, 2024 Firdapse® Tablet 10mg Approved for the Treatment of Muscle Weakness in Lambert-Eaton Myasthenic Syndrome in Japan
- Whats new December 18, 2023 Submission of new drug application of amifampridine phosphate (3,4-diaminopyridine) for Lambert-Eaton myasthenic syndrome (LEMS) in Japan
- Whats new July 24, 2023 Results of a Phase 3 study of Amifampridine phosphate (3,4-diaminopyridine) for Lambert-Eaton myasthenia syndrome (LEMS) in Japan
- Whats new July 15, 2022 Acquisition of Marketing Licenses for Pharmaceuticals
- Product-related December 6, 2021 Phase 3 Clinical Trial（LEMS）
- Product-related June 28, 2021 Singed a license agreement.（LEMS）
- Product-related January 15, 2021 Singed a license agreement.（LCAT）
- Whats new April 3, 2019 DyDo Pharma website launched.